Business Wire
Global Botulinum Toxin Market: Size, Trends and Forecasts Through 2018-2022, with Profiles for Allergan, Ipsen and Revance - ResearchAndMarkets.com
Tuesday, 01 January 2019 20:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Central Nervous System Drugs
Read more...
 
Global Antacids Market Outlook to 2023; Led by Bayer, GlaxoSmithKline, Johnson & Johnson Services, Novartis and Sanofi - ResearchAndMarkets.com
Tuesday, 01 January 2019 20:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Gastrointestinal Drugs
Read more...
 
Global Antacids Market Outlook to 2023; Led by Bayer, GlaxoSmithKline, Johnson & Johnson Services, Novartis and Sanofi - ResearchAndMarkets.com
Tuesday, 01 January 2019 20:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Gastrointestinal Drugs
Read more...
 
Promethera Biosciences Announces Investment by ITOCHU Corporation and a Broad Strategic Collaboration to Access the Asian Markets
Tuesday, 01 January 2019 20:06
First anchor investor in upcoming Series D financing round commits EUR10 million and intends to support Promethera broadly in R&D, BD and through its Medical Network in Asia
Read more...
 
Promethera Biosciences Announces Investment by ITOCHU Corporation and a Broad Strategic Collaboration to Access the Asian Markets
Tuesday, 01 January 2019 20:06
First anchor investor in upcoming Series D financing round commits EUR10 million and intends to support Promethera broadly in R&D, BD and through its Medical Network in Asia
Read more...
 
<< Start < Prev 61 62 63 64 65 66 67 68 Next > End >>

Page 68 of 68

Newsletter